World Thrombosis Day (WTD) Call To Action, October 13, 2015 – To learn more about WTD and its goals, please visit www.worldthrombosisday.org. The entire WTD press release and list of references can be viewed at WTD Press Release.
This year over 300 medical societies, government health agencies, and advocacy groups across 70 countries called on their health care systems to require venous thromboembolism (VTE) risk assessment in hospitals. VTE refers collectively to blood clots in the leg (DVT) and the lungs (PE). The WTD call for VTE risk assessment is supported by these telling statistics – VTE is a leading cause of preventable death in hospitals worldwide; and when enforced, risk assessments have been associated with reductions of VTE-related deaths among hospital patients.
WTD will also focus on public education, and urges people going into the hospital to request a VTE risk assessment. Family members can be proactive by asking for a VTE risk assessment for loved ones who are unable to advocate for themselves.
Led by the International Society on Thrombosis and Haemostasis, the World Thrombosis Day (WTD) coalition’s goal is to raise awareness of blood clot formation (thrombosis) and a condition that kills approximately 1 in 4 people around the world. WTD reported that an estimated 10 million cases of VTE occur worldwide each year, and that more than 600,000 people die from VTE in the United States and Europe each year.
Gary Raskob, Ph.D., dean of the College of Public Health at the University of Oklahoma Health Sciences Center, and chairman of the World Thrombosis Day Steering Committee stated:
“A patient going into the hospital is at an increased risk for developing VTE, whether admitted for surgery or medical illness. People need to know that hospitalization is a leading risk factor for VTE, and hospitals owe it to their patients to be vigilant about performing VTE risk assessments on every patient. The results of that assessment should be used to decide about the use of evidence-based preventive measures against VTE.”
About Venous Thromboembolism (VTE), Deep Vein Blood Clots (DVT), and Pulmonary Embolism (PE), Or… VTE = DVT + PE
Venous thromboembolism (VTE) refers collectively to:
1.) Deep Vein Thrombosis (DVT), a blood clot that occurs in a deep vein (usually in the leg); and
2.) Pulmonary Embolism (PE), a blood clot that breaks loose and travels to the lungs. This is a life-threatening condition that requires immediate medical care.
WTD wants the public to recognize signs and symptoms that might indicate DVT or PE:
“DVT or blood clot in the leg: Indicators include pain/tenderness or swelling often starting in the calf; redness, noticeable changes in color and/or warmth in the leg.
PE or blood clot in the lung: Indicators include unexplained shortness of breath or rapid breathing; chest pain (sometimes worse upon a deep breath); rapid heart rate; and/or light headedness or passing out.
While these indicators do not necessarily mean the presence of VTE, a medical professional should assess them immediately.
Go to www.WorldThrombosisDay.org to learn more about VTE, the signs and symptoms, key risk factors and how to prevent it.
To watch an animated video on VTE, visit https://youtu.be/GfPfqMF03w8.”
Obtain a Free Pulmonary Embolism Lawsuit Case Evaluation
If you or a loved one has suffered a pulmonary embolism or blood clots related to a medical malpractice issue or drug side effect, and you have a question regarding a potential pulmonary embolism lawsuit, please call The Weinberg Law Firm toll free at 877-934-6274.
Learn more about Pharmaceutical Drug Lawsuits by visiting Accutane,Invokana, Benicar, Yaz, Zofran, Testosterone, and Pradaxa.
